Literature DB >> 1277705

Adverse drug reactions-a matter of opinion.

F E Karch, C L Smith, B Kerzner, J M Mazzullo, M Weintraub, L Lasagna.   

Abstract

The accurate identification of adverse drug reactions (ADRs) is difficult because ADRs usually present no unique clinical or laboratory findings that demarcate them from the manifestations of concurrent illnesses. The identification of ADRs depends on the clinical assessments of physicians-sometimes the clinician treating the patient and at other times a clinical pharmacologist. Considering the complex and subjective nature of clinically identifying ADRs, how accurately are ADRs identified? To answer this question, three clinical pharmacologists each independently evaluated 60 selected cases to determine if medication, alcohol, or "recreational" drugs had caused the hospitalization. The three clinical pharmacologists agreed on only 30 cases (50%), and 27 of these were thought to be unrelated to medications. In 19 of the 30 cases about which the clinical pharmacologists disagreed, they disagreed on whether or not a medication-or alcohol-related event had occurred at all. The clinical pharmacologists disagreed with the physicians treating the patient in 22% to 37% of the cases, but because of the differences among the pharmacologists, the treating physicians agreed with at least one of them in 95% of the cases. Complete agreement between the clinical pharmacologists and the treating physicians occurred in 47% of the cases. This degree of disparity in the clinical identification of ADRs shows that the evaluation of ADRs is subjective and imprecise. The accurate identification of ADRs awaits the development of an objective technique for recognizing ADRs.

Entities:  

Mesh:

Year:  1976        PMID: 1277705     DOI: 10.1002/cpt1976195part1489

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  40 in total

1.  Hematologic dyscrasia associated with ticlopidine therapy: evidence for causality.

Authors:  F L Paradiso-Hardy; C M Angelo; K L Lanctôt; E A Cohen
Journal:  CMAJ       Date:  2000-11-28       Impact factor: 8.262

2.  Adverse events in British hospitals. Preventive strategies, not epidemiological studies, are needed.

Authors:  T V Nguyen; K M Hillman; M D Buist
Journal:  BMJ       Date:  2001-06-09

3.  Comparison of three methods (consensual expert judgement, algorithmic and probabilistic approaches) of causality assessment of adverse drug reactions: an assessment using reports made to a French pharmacovigilance centre.

Authors:  Hélène Théophile; Yannick Arimone; Ghada Miremont-Salamé; Nicholas Moore; Annie Fourrier-Réglat; Françoise Haramburu; Bernard Bégaud
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

4.  Comparison of three pharmacovigilance algorithms in the ICU setting: a retrospective and prospective evaluation of ADRs.

Authors:  Sandra L Kane-Gill; Elizabeth A Forsberg; Margaret M Verrico; Steven M Handler
Journal:  Drug Saf       Date:  2012-08-01       Impact factor: 5.606

5.  Agreement of expert judgment in causality assessment of adverse drug reactions.

Authors:  Yannick Arimone; Bernard Bégaud; Ghada Miremont-Salamé; Annie Fourrier-Réglat; Nicholas Moore; Mathieu Molimard; Françoise Haramburu
Journal:  Eur J Clin Pharmacol       Date:  2005-04-13       Impact factor: 2.953

Review 6.  The art and science of risk management: a US research-based industry perspective.

Authors:  Janice K Bush; Wanju S Dai; Gretchen S Dieck; Linda S Hostelley; Thomas Hassall
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

7.  Can decisional algorithms replace global introspection in the individual causality assessment of spontaneously reported ADRs?

Authors:  Ana F Macedo; Francisco B Marques; Carlos F Ribeiro
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 8.  Methods for causality assessment of adverse drug reactions: a systematic review.

Authors:  Taofikat B Agbabiaka; Jelena Savović; Edzard Ernst
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

9.  Inter-expert agreement of seven criteria in causality assessment of adverse drug reactions.

Authors:  Yannick Arimone; Ghada Miremont-Salamé; Françoise Haramburu; Mathieu Molimard; Nicholas Moore; Annie Fourrier-Réglat; Bernard Bégaud
Journal:  Br J Clin Pharmacol       Date:  2007-08-15       Impact factor: 4.335

10.  Risk factors for acute kidney injury in older adults with critical illness: a retrospective cohort study.

Authors:  Sandra L Kane-Gill; Florentina E Sileanu; Raghavan Murugan; Gregory S Trietley; Steven M Handler; John A Kellum
Journal:  Am J Kidney Dis       Date:  2014-12-06       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.